Phd Frederique Menzaghi - Chief Scientific OffSVP-R&D, Cara Therapeutics, Inc

As of September 1, 2021


Phd Frederique Menzaghi Net Worth

  • Net worth is estimated to be at least $5.96M
  • Owns at least 141,072 units of Cara Therapeutics, Inc stock
  • Sold an estimated value of $4.8M in the last 7 years at Cara Therapeutics, Inc

Phd Frederique Menzaghi Trading

  • Largest purchase of shares was 40,000 units , worth over $82K on November 5, 2018
  • Largest sale of shares was 20,000 units , worth over $464.8K on August 5, 2019
  • In total has made about 52 transactions over 7 years
  • Usually trades in March, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Phd Frederique Menzaghi Mailing Address

  • Mailing address is C/o Cara Therapeutics, Inc. 1 Parrott Drive Shelton CT 06484 CT

Cara Therapeutics, Inc Insider Trading

  • The most recent transaction was 20,000 units sold on September 9, 2021 by Derek Chalmers worth over $309.4K
  • In the last 7 years, insiders at Cara Therapeutics, Inc sold an estimated value of $26.08M and bought an estimated value of $21.17M
  • The most active traders are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Jeffrey Ives, Director
  • Insider trading is most common in June, with the busiest year in 2020

Cara Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1